...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >COMPARISON OF EFFICACY AND ADVERSE DRUG REACTIONS OF MONOTHERAPY VERSUS COMBINATION THERAPY OF ANTIHYPERTENSIVES AMONG DIABETIC HYPERTENSIVE PATIENTS IN A TERTIARY CARE HOSPITAL
【24h】

COMPARISON OF EFFICACY AND ADVERSE DRUG REACTIONS OF MONOTHERAPY VERSUS COMBINATION THERAPY OF ANTIHYPERTENSIVES AMONG DIABETIC HYPERTENSIVE PATIENTS IN A TERTIARY CARE HOSPITAL

机译:三联医院糖尿病高血压患者抗高血压药单药治疗与药物联合治疗的疗效和不良反应的比较

获取原文
           

摘要

Objective: To compare the efficacy and adverse drug reactions of monotherapy and combination therapy of antihypertensive drugs in diabetic hypertensive patients. Methods: A prospective observational study of 18 months duration was conducted in the Department of Medicine of a tertiary care hospital in South India. A total of 200 patients were included in the study. Using a standard proforma the details of patients like demographic data, antihypertensive medications etc. were collected and analysed for efficacy and safety. Results: Out of 200 patients studied, 50% received monotherapy whereas the remaining 50% received combination therapy. There was male preponderance (54%) in the study population with the mean age being 60.07±11.32 years. In monotherapy group, most commonly prescribed drug was Amlodipine (38%) whereas in combination group, Angiotensin receptor blocker (ARB) or calcium channel blocker (CCB) + beta blocker (18%) was commonly prescribed among 2-drug group and ARB+ thiazide+ CCB (25.6%) among 3-drug group. Monotherapy and combination therapy were analysed to be equally efficacious in reducing SBP and DBP. Based on adverse effect profile, monotherapy comparatively produced more adverse effects than combination group. Amlodipine induced pedal edema (56.7%) was the most common adverse effect observed and it was predominantly managed by changing it to a better tolerable CCB, namely Cilnidipine. Conclusion: In conclusion, combination therapy may be a better treatment option in selected patient population. Key words: systolic blood pressure, diastolic blood pressure, Amlodipine, Cilnidipine, pedal edema.
机译:目的:比较单药联合降压药对糖尿病高血压患者的疗效和不良反应。方法:在印度南部一家三级护理医院的医学部进行了为期18个月的前瞻性观察研究。该研究总共包括200名患者。使用标准形式收集患者的详细信息,例如人口统计数据,降压药物等,并分析其疗效和安全性。结果:在研究的200名患者中,有50%接受了单一疗法,而其余50%接受了联合疗法。研究人群中男性占多数(54%),平均年龄为60.07±11.32岁。在单药治疗组中,最常用的药物是氨氯地平(38%),而在联合治疗组中,在2药组和ARB +噻嗪+中,通常使用血管紧张素受体阻滞剂(ARB)或钙通道阻滞剂(CCB)+β阻滞剂(18%)。 3种药物组中的CCB(25.6%)。据分析,单一疗法和联合疗法在降低SBP和DBP方面同样有效。根据不良反应情况,单药治疗比联合治疗组产生更多的不良反应。观察到的最常见的不良反应是氨氯地平诱发的踏板水肿(56.7%),并且主要通过将其改为耐受性更好的CCB(西尼地平)来控制。结论:总之,联合治疗可能是特定患者人群的更好治疗选择。关键词:收缩压,舒张压,氨氯地平,西尼地平,踏板水肿。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号